The associations of oxaliplatin-induced peripheral neuropathy, sociodemographic characteristics, and clinical characteristics with time to fall in older adults with colorectal cancer

被引:2
|
作者
Hines, Robert B. [1 ]
Schoborg, Christopher [2 ]
Sumner, Timothy [2 ]
Thiesfeldt, Dana-Leigh [3 ]
Zhang, Shunpu [2 ]
机构
[1] Univ Cent Florida, Coll Med, Dept Populat Hlth Sci, 900 Lake NonaBlvd, Orlando, FL 32827 USA
[2] Univ Cent Florida, Coll Sci, Dept Stat & Data Sci, Orlando, FL 32827 USA
[3] Univ Cent Florida, Coll Med, Dept Med Educ, Orlando, FL 32827 USA
关键词
colorectal cancer; chemotherapy-induced peripheral neuropathy; oxaliplatin; falls; QUALITY-OF-LIFE; RISK-FACTORS; ADJUVANT TREATMENT; CHEMOTHERAPY; HEALTH; INJURIES; CIRRHOSIS; FRAILTY; PEOPLE; CLAIMS;
D O I
10.1093/aje/kwae067
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our purpose was to investigate the associations between falls and oxaliplatin-induced peripheral neuropathy (OIPN), sociodemographic characteristics, and clinical characteristics of older patients with colorectal cancer. The study population consisted of older adults diagnosed with colorectal cancer whose data were obtained from the Surveillance, Epidemiology, and End Results database combined with Medicare claims. We defined OIPN using specific (OIPN 1) and broader (OIPN 2) definitions of OIPN, based on diagnosis codes. Extensions of the Cox regression model to accommodate repeated events were used to obtain overall hazard ratios (HRs) with 95% CIs and the cumulative hazard of fall. The unadjusted risk of fall for colorectal cancer survivors with versus without OIPN 1 at 36 months of follow-up was 19.6% versus 14.3%, respectively. The association of OIPN with time to fall was moderate (for OIPN 1, HR = 1.37; 95% CI, 1.04-1.79) to small (for OIPN 2, HR = 1.24; 95% CI, 1.01-1.53). Memantine, opioids, cannabinoids, prior history of fall, female sex, advanced age and disease stage, chronic liver disease, diabetes, and chronic obstructive pulmonary disease all increased the hazard rate of falling. Incorporating fall prevention in cancer care is essential to minimize morbidity and mortality of this serious event in older survivors of colorectal cancer.
引用
收藏
页码:1271 / 1280
页数:10
相关论文
共 50 条
  • [41] Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients
    Wang, Wei-Shu
    Lin, Jen-Kou
    Lin, Tzu-Chen
    Chen, Wei-Shone
    Jiang, Jeng-Kae
    Wang, Huann-Sheng
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Yen, Chueh-Chuan
    Chen, Po-Min
    ONCOLOGIST, 2007, 12 (03) : 312 - 319
  • [42] Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients
    Won, Hong-Hee
    Lee, Jeeyun
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Jong-Won
    Lee, Soo-Youn
    Park, Se Hoon
    CANCER, 2012, 118 (11) : 2828 - 2836
  • [43] Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
    Masanobu Tsubaki
    Tomoya Takeda
    Takuya Matsuda
    Kana Kishimoto
    Honoka Takefuji
    Yuzuki Taniwaki
    Misa Ueda
    Tadafumi Hoshida
    Kazufumi Tanabe
    Shozo Nishida
    Cancer Cell International, 23
  • [44] Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
    Tsubaki, Masanobu
    Takeda, Tomoya
    Matsuda, Takuya
    Kishimoto, Kana
    Takefuji, Honoka
    Taniwaki, Yuzuki
    Ueda, Misa
    Hoshida, Tadafumi
    Tanabe, Kazufumi
    Nishida, Shozo
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [45] Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial
    de Afonseca, Samuel Oliveira
    Cruz, Felipe Melo
    Gomes Cubero, Daniel de Iracema
    Lera, Andrea Thaumaturgo
    Schindler, Fernanda
    Okawara, Marcia
    de Souza, Luiz Fernando
    Rodrigues, Nataly Pimentel
    del Giglio, Auro
    SAO PAULO MEDICAL JOURNAL, 2013, 131 (01): : 35 - 38
  • [46] Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies
    Ramanathan, R. K.
    Rothenberg, M. L.
    de Gramont, A.
    Tournigand, C.
    Goldberg, R. M.
    Gupta, S.
    Andre, T.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 754 - 758
  • [47] Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer
    Baek, Kyung Kee
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Cho, Yong Beom
    Yun, Seong Hyeon
    Kim, Hee Cheol
    Lee, Woo Yong
    Chun, Ho-Kyung
    CANCER RESEARCH AND TREATMENT, 2010, 42 (04): : 185 - 190
  • [48] Relationship Between Frailty, Sociodemographic and Clinical Characteristics, and Disease Severity of Older Adults With Acute Coronary Syndrome
    Pontes Goncalves, Alexia Louisie
    Grisante, Daiane Lopes
    Silva, Renan Alves
    Santos, Vinicius Batista
    Lopes, Camila Takao
    CLINICAL NURSING RESEARCH, 2023, 32 (03) : 677 - 687
  • [49] The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer
    Kyoko Yamaguchi
    Hitoshi Kusaba
    Akitaka Makiyama
    Kenji Mitsugi
    Keita Uchino
    Shingo Tamura
    Yoshihiro Shibata
    Taito Esaki
    Mamoru Ito
    Kotoe Takayoshi
    Kenji Tsuchihashi
    Shuji Arita
    Hiroshi Ariyama
    Koichi Akashi
    Eishi Baba
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 625 - 633
  • [50] Characteristics of the gait initiation phase in older adults with diabetic peripheral neuropathy compared to control older adults
    Kang, Gu Eon
    Zhou, He
    Varghese, Varsha
    Najafi, Bijan
    CLINICAL BIOMECHANICS, 2020, 72 : 155 - 160